Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Nov 21, 2022; 28(43): 6157-6167
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6157
Table 2 Demography, celiac disease serology, and endoscopic findings of the overall population and by the age of diagnosis
Demographic data and upper GI endoscopic findings
Overall CeD population
≤ 50 yr
51-60 yr
≥ 61 yr
Patients13281140 (85.8)114 (8.6)74 (5.6)
Age in yr35 (26-43)33 (25-39)55 (53-56)67 (63-71)
Female sex1064 (80.1)931 (81.7)82 (71.9)51 (41.0)
Patients with positive serology1269 (95.6)1092 (95.8)109 (95.6)68 (91.9)
Patients with at least one significant endoscopic abnormalities135 (10.1)102 (8.9)120 (17.5)13 (17.6)
Reflux esophagitis with erosions85 (6.4)69 (6.0)12 (10.5)4 (5.4)
Esophageal ulcers1 (0.2)1 (0.1)00
Esophageal cancer0000
Suspicion of metaplasia16 (1.2)10 (0.9)3 (2.6)2 (2.7)
Biopsy confirmed Barrett’s esophagus3 (0.2)2 (0.2)01 (1.3)
Gastric erosions27 (2.0)20 (1.7)3 (2.6)4 (5.4)
Gastric ulcers1 (0.1)1 (0.1)00
Gastric cancer0000
Duodenal erosions15 (1.1)8 (0.7)3 (2.6)4 (5.4)
Duodenal ulcers15 (1.1)10 (0.9)4 (3.5)1 (1.3)
Duodenal cancer0000